G. E. Gendlin
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Atrial Fibrillation Management and Outcomes
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Heart rate and cardiovascular health
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 8
- Heart Failure Treatment and Management 3
- Cardiovascular Function and Risk Factors 3
- Atrial Fibrillation Management and Outcomes 3
-
- Cardiac Imaging and Diagnostics 6
- Co-authors
- И. Г. Никитин (14 shared papers)Yu. A. Vasyuk (6 shared papers)А. В. Мелехов (4 shared papers)Evgeny Shkolnik (1 shared paper)Olga Tronina (1 shared paper)Natalia Tomilina (2 shared papers)M. Yu. Sitnikova (1 shared paper)Н. А. Козиолова (1 shared paper)
- Journals
- CARDIOVASCULAR THERAPY AND PREVENTION (3 papers)Kardiologiia (6 papers)Rational Pharmacotherapy in Cardiology (2 papers)Russian Journal of Cardiology (2 papers)Clinical oncohematology (1 paper)
- Partner nations
- RussiaUnited StatesTajikistan
In The Last Decade
G. E. Gendlin
23 papers receiving 61 citations
Peers
Comparison fields: 5 of 32
- Cardiology and Cardiovascular Medicine 48
- Internal Medicine 4
- Transplantation 2
- Health Informatics 1
- Hematology 6
Countries citing papers authored by G. E. Gendlin
This map shows the geographic impact of G. E. Gendlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. E. Gendlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. E. Gendlin more than expected).
Fields of papers citing papers by G. E. Gendlin
This network shows the impact of papers produced by G. E. Gendlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. E. Gendlin. The network helps show where G. E. Gendlin may publish in the future.
Co-authors
The 25 scholars most cited alongside G. E. Gendlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 10 | |
| 2 | 2017 | 6 | |
| 3 | [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney]. | 2007 | 6 |
| 4 | 2020 | 5 | |
| 5 | 2017 | 5 | |
| 6 | 2016 | 4 | |
| 7 | 2019 | 3 | |
| 8 | 2016 | 3 | |
| 9 | [Left ventricular myocardial hypertrophy after transplantation of the kidney: risk factors and possible regress]. | 2009 | 3 |
| 10 | 2017 | 3 | |
| 11 | 2021 | 2 | |
| 12 | 2020 | 2 | |
| 13 | 2017 | 2 | |
| 14 | 2018 | 2 | |
| 15 | 2013 | 1 | |
| 16 | 2017 | 1 | |
| 17 | 2016 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2023 | 1 |
About G. E. Gendlin
G. E. Gendlin is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Genetics, Pathology and Forensic Medicine and Epidemiology, having authored 27 papers that have together received 68 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (8 papers), Cardiac Imaging and Diagnostics (6 papers), Healthcare Systems and Public Health (3 papers), Heart Failure Treatment and Management (3 papers), Cardiovascular Function and Risk Factors (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (48 citations), Internal Medicine (4 citations), Transplantation (2 citations), Health Informatics (1 citation) and Hematology (6 citations). G. E. Gendlin has collaborated with scholars based in Russia, United States and Tajikistan. Frequent co-authors include И. Г. Никитин, Yu. A. Vasyuk, А. В. Мелехов, Evgeny Shkolnik, Olga Tronina, Natalia Tomilina, M. Yu. Sitnikova, Н. А. Козиолова, E. I. Tarlovskaya and Zhanna Kobalava. Their work appears in journals such as CARDIOVASCULAR THERAPY AND PREVENTION, Kardiologiia, Rational Pharmacotherapy in Cardiology, Russian Journal of Cardiology and Clinical oncohematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.